Integer Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Integer stock.
View analyst ratings for Integer or view top-rated stocks.

Wall Street analysts have given Integer a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Integer wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Integer is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Integer.

Integer Holdings Co. (NYSE:ITGR) posted its quarterly earnings data on Thursday, July, 29th. The medical equipment provider reported $1.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.16. The medical equipment provider earned $312.02 million during the quarter, compared to the consensus estimate of $292.50 million. Integer had a net margin of 8.73% and a trailing twelve-month return on equity of 8.46%.
View Integer's earnings history.

Integer's stock was trading at $79.33 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ITGR shares have increased by 15.5% and is now trading at $91.59.
View which stocks have been most impacted by COVID-19.

Integer updated its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share (EPS) guidance of $3.660-$4.030 for the period, compared to the Thomson Reuters consensus estimate of $3.820. The company issued revenue guidance of $1.20 billion-$1.22 billion, compared to the consensus revenue estimate of $1.19 billion.

2 Wall Street analysts have issued 12-month price objectives for Integer's stock. Their forecasts range from $105.00 to $107.00. On average, they anticipate Integer's share price to reach $106.00 in the next twelve months. This suggests a possible upside of 15.7% from the stock's current price.
View analysts' price targets for Integer or view top-rated stocks among Wall Street analysts.

40 employees have rated Integer CEO Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among Integer's employees.

Some companies that are related to Integer include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), Baxter International (BAX), ResMed (RMD), STERIS (STE), Insulet (PODD), Hologic (HOLX) and Teleflex (TFX).
View all of ITGR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), The Procter & Gamble (PG), Gilead Sciences (GILD), The Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Integer's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.58%), Vanguard Group Inc. (10.71%), Dimensional Fund Advisors LP (5.86%), Franklin Resources Inc. (5.39%), State Street Corp (3.65%) and Macquarie Group Ltd. (3.11%). Company insiders that own Integer stock include Anthony W Borowicz, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic, Pamela G Bailey and Peter H Soderberg.
View institutional ownership trends for Integer.

ITGR stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Hawk Ridge Capital Management LP, William Blair Investment Management LLC, Goldman Sachs Group Inc., Fisher Asset Management LLC, RK Capital Management LLC, California Public Employees Retirement System, and BlackRock Inc.. Company insiders that have sold Integer company stock in the last year include Anthony W Borowicz, Bill R Sanford, Carter Houghton, Jean M Hobby, and Joseph F Flanagan.
View insider buying and selling activity for Integer or view top insider-selling stocks.

ITGR stock was purchased by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., JPMorgan Chase & Co., Prudential Financial Inc., Morgan Stanley, Morgan Stanley, New York State Common Retirement Fund, Chartwell Investment Partners LLC, and Dimensional Fund Advisors LP.
View insider buying and selling activity for Integer or or view top insider-buying stocks.

Shares of ITGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ITGR stock can currently be purchased for approximately $91.59.

Integer has a market capitalization of $3.02 billion and generates $1.07 billion in revenue each year. The medical equipment provider earns $77.26 million in net income (profit) each year or $2.77 on an earnings per share basis.

Integer employs 7,500 workers across the globe.

The official website for Integer is www.integer.net.

Integer is headquartered at 5830 Granite Parkway Suite 1150, Plano TX, 75024.

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The medical equipment provider can be reached via phone at (214) 618-5243 or via email at [email protected].